Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Duration of Immune Response to Influenza Vaccination in Patients With Rheumatoid Arthritis Receiving Treatment With Biologic Agents

NCT02311855 is registered in ClinicalTrials.gov with Bassett Healthcare as lead sponsor.

NCT NCT02311855
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02311855 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Duration of Immune Response to Influenza Vaccination in Patients With Rheumatoid Arthritis Receiving Treatment With Biologic Agents
Lead sponsor
Bassett Healthcare
Phase
Phase 4
Overall status
Completed
Start date
August 31, 2014
Completion date
February 29, 2016
Enrollment
87 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

rheumatoid arthritis